BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarlos P, Szemes K, Hegyi P, Garami A, Szabo I, Illes A, Solymar M, Petervari E, Vincze A, Par G, Bajor J, Czimmer J, Huszar O, Varju P, Farkas N. Steroid but not Biological Therapy Elevates the risk of Venous Thromboembolic Events in Inflammatory Bowel Disease: A Meta-Analysis. J Crohns Colitis. 2018;12:489-498. [PMID: 29220427 DOI: 10.1093/ecco-jcc/jjx162] [Cited by in Crossref: 32] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 S Y, Kedia S, Teja V, Vuyyuru SK, Yadav N, Sahu P, Jain S, Yadav DP, Bopanna S, Mouli VP, Madhu D, Sharma R, Das P, Makharia G, Ahuja V. Thromboembolism is associated with poor prognosis and high mortality in patients with inflammatory bowel disease: A case-control study. Indian J Gastroenterol 2022. [PMID: 36063357 DOI: 10.1007/s12664-021-01237-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Carvalho AC, Pinho J, Cancela E, Vieira HM, Silva A, Ministro P. Inflammatory bowel disease and thromboembolic events: a c’lot to learn. Therap Adv Gastroenterol 2022;15:175628482211006. [DOI: 10.1177/17562848221100626] [Reference Citation Analysis]
3 Klomberg RCW, Vlug LE, de Koning BAE, de Ridder L. Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure. Front Pediatr 2022;10:885876. [PMID: 35601436 DOI: 10.3389/fped.2022.885876] [Reference Citation Analysis]
4 Melazzini F, Calabretta F, Lenti MV, Di Sabatino A. Venous thromboembolism in chronic gastrointestinal disorders. Expert Rev Gastroenterol Hepatol 2022;16:437-48. [PMID: 35502886 DOI: 10.1080/17474124.2022.2072295] [Reference Citation Analysis]
5 Fujiya M, Kawaguchi T, Arai S, Isogawa N, Hiro S, Matsumoto F, Yamaguchi S, Yoshii N, Nakamura M, Matsuoka K. Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease. Dig Dis Sci 2022. [PMID: 35150345 DOI: 10.1007/s10620-022-07388-w] [Reference Citation Analysis]
6 Lin H, Bai Z, Meng F, Wu Y, Luo L, Shukla A, Yoshida EM, Guo X, Qi X. Epidemiology and Risk Factors of Portal Venous System Thrombosis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:744505. [PMID: 35111772 DOI: 10.3389/fmed.2021.744505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Setyawan J, Mu F, Zichlin ML, Billmyer E, Downes N, Yang H, Azimi N, Strand V, Yarur A. Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease. Adv Ther 2022;39:738-53. [PMID: 34877631 DOI: 10.1007/s12325-021-01973-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Aardoom MA, Klomberg RCW, Kemos P, Ruemmele FM, van Ommen H, de Ridder L, Croft NM. The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease; a prospective international cohort study based on the PIBD-SETQuality Safety Registry. J Crohns Colitis 2021:jjab171. [PMID: 34599822 DOI: 10.1093/ecco-jcc/jjab171] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Lee KE, Lim F, Colombel JF, Hur C, Faye AS. Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021:izab246. [PMID: 34591970 DOI: 10.1093/ibd/izab246] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Arvanitakis KD, Arvanitaki AD, Karkos CD, Zintzaras EΑ, Germanidis GS. The risk of venous thromboembolic events in patients with inflammatory bowel disease: a systematic review and meta-analysis. Ann Gastroenterol 2021;34:680-90. [PMID: 34475739 DOI: 10.20524/aog.2021.0631] [Reference Citation Analysis]
11 Olivera PA, Zuily S, Kotze PG, Regnault V, Al Awadhi S, Bossuyt P, Gearry RB, Ghosh S, Kobayashi T, Lacolley P, Louis E, Magro F, Ng SC, Papa A, Raine T, Teixeira FV, Rubin DT, Danese S, Peyrin-Biroulet L. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34453143 DOI: 10.1038/s41575-021-00492-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
12 Chen CP, Kung PT, Chou WY, Tsai WC. Effect of introducing biologics to patients with rheumatoid arthritis on the risk of venous thromboembolism: a nationwide cohort study. Sci Rep 2021;11:17009. [PMID: 34426637 DOI: 10.1038/s41598-021-96508-z] [Reference Citation Analysis]
13 Dorrington AM, Selinger CP, Parkes GC, Smith M, Pollok RC, Raine T. The Historical Role and Contemporary Use of Corticosteroids in Inflammatory Bowel Disease. J Crohns Colitis. 2020;14:1316-1329. [PMID: 32170314 DOI: 10.1093/ecco-jcc/jjaa053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
14 Sleutjes JAM, van Lennep JER, van der Woude CJ, de Vries AC. Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management. Therap Adv Gastroenterol 2021;14:17562848211032126. [PMID: 34377149 DOI: 10.1177/17562848211032126] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Mitchel EB, Rosenbaum S, Gaeta C, Huang J, Raffini LJ, Baldassano RN, Denburg MR, Albenberg L. Venous Thromboembolism in Pediatric Inflammatory Bowel Disease: A Case-Control Study. J Pediatr Gastroenterol Nutr 2021;72:742-7. [PMID: 33605670 DOI: 10.1097/MPG.0000000000003078] [Reference Citation Analysis]
16 Setyawan J, Mu F, Yarur A, Zichlin ML, Yang H, Fernan C, Billmyer E, Downes N, Azimi N, Strand V. Risk of thromboembolic events and associated risk factors, including treatments, in patients with immune-mediated diseases. Clin Ther 2021:S0149-2918(21)00239-3. [PMID: 34238587 DOI: 10.1016/j.clinthera.2021.06.008] [Reference Citation Analysis]
17 Zhang H, Wang X. Risk Factors of Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:693927. [PMID: 34262920 DOI: 10.3389/fmed.2021.693927] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
18 Shen X, Wan Q, Zhao R, Wu Y, Wang Y, Cui Y, Su X, Wu X. Inflammatory bowel diseases and the risk of adverse health outcomes: Umbrella review of meta-analyses of observational studies. Dig Liver Dis 2021;53:809-16. [PMID: 33551353 DOI: 10.1016/j.dld.2021.01.018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Solitano V, Fiorino G, D'Amico F, Peyrin-Biroulet L, Danese S. Thrombosis in IBD in the Era of JAK Inhibition. Curr Drug Targets 2021;22:126-36. [PMID: 32881668 DOI: 10.2174/1389450121666200902164240] [Reference Citation Analysis]
20 Naito T, Botwin GJ, Haritunians T, Li D, Yang S, Khrom M, Braun J, Abbou L, Mengesha E, Stevens C, Masamune A, Daly M, McGovern DPB; NIDDK IBD Genetics Consortium. Prevalence and Effect of Genetic Risk of Thromboembolic Disease in Inflammatory Bowel Disease. Gastroenterology 2021;160:771-780.e4. [PMID: 33098885 DOI: 10.1053/j.gastro.2020.10.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Murthy SK, Robertson Mccurdy AB, Carrier M, Mccurdy JD. Venous thromboembolic events in inflammatory bowel diseases: A review of current evidence and guidance on risk in the post-hospitalization setting. Thrombosis Research 2020;194:26-32. [DOI: 10.1016/j.thromres.2020.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Vakharia RM, Adams CT, Anoushiravani AA, Ehiorobo JO, Mont MA, Roche MW. Chronic Obstructive Pulmonary Disease Is Associated With Higher Rates of Venous Thromboemboli Following Primary Total Knee Arthroplasty. The Journal of Arthroplasty 2020;35:2066-2071.e9. [DOI: 10.1016/j.arth.2020.03.053] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
23 Papa A, Tursi A, Danese S, Rapaccini G, Gasbarrini A, Papa V. Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery. J Clin Med 2020;9:E2115. [PMID: 32635542 DOI: 10.3390/jcm9072115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
24 Cheng K, Faye AS. Venous thromboembolism in inflammatory bowel disease. World J Gastroenterol 2020; 26(12): 1231-1241 [PMID: 32256013 DOI: 10.3748/wjg.v26.i12.1231] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 29] [Article Influence: 17.5] [Reference Citation Analysis]
25 Mccurdy JD, Benchimol EI. Response to Letter, “Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease”. Inflammatory Bowel Diseases 2020;26:e45-e45. [DOI: 10.1093/ibd/izaa051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Lagrange J, Lacolley P, Wahl D, Peyrin-Biroulet L, Regnault V. Shedding Light on Hemostasis in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2021;19:1088-1097.e6. [PMID: 31972287 DOI: 10.1016/j.cgh.2019.12.043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
27 Lenti MV, Armuzzi A, Castiglione F, Fantini MC, Fiorino G, Orlando A, Pugliese D, Rizzello F, Vecchi M, Di Sabatino A. Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign. Digestive and Liver Disease 2020;52:44-50. [DOI: 10.1016/j.dld.2019.09.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
28 Xie W, Xiao S, Huang Y, Sun X, Zhang Z. Effect of tofacitinib on cardiovascular events and all-cause mortality in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials. Ther Adv Musculoskelet Dis 2019;11:1759720X19895492. [PMID: 31897092 DOI: 10.1177/1759720X19895492] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
29 Ogino T, Mizushima T, Matsuda C, Mori M, Doki Y. Essential updates 2018/2019: Colorectal (benign): Recent updates (2018-2019) in the surgical treatment of benign colorectal diseases. Ann Gastroenterol Surg 2020;4:30-8. [PMID: 32021956 DOI: 10.1002/ags3.12304] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
30 Detrez I, Thomas D, Van Steen K, Ballet V, Peeters M, Hoylaerts MF, Van Assche G, Vermeire S, Ferrante M, Gils A. Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients. Journal of Clinical Gastroenterology 2020;54:819-25. [DOI: 10.1097/mcg.0000000000001290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
31 Ashton JJ, Green Z, Kolimarala V, Beattie RM. Inflammatory bowel disease: long-term therapeutic challenges. Expert Rev Gastroenterol Hepatol 2019;13:1049-63. [PMID: 31657969 DOI: 10.1080/17474124.2019.1685872] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Seyahi E. Venous involvement in inflammatory disorders. Curr Opin Rheumatol 2020;32:29-34. [PMID: 31599799 DOI: 10.1097/BOR.0000000000000670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
33 Deskur A, Zawada I, Błogowski W, Starzyńska T. Cerebral venous sinus thrombosis in a young patient with ulcerative colitis: A case report. Medicine (Baltimore) 2019;98:e17428. [PMID: 31593096 DOI: 10.1097/MD.0000000000017428] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Dhir A, Demarsh S, Ramgopal A, Worley S, Auron M, Hupertz V, Onimoe G. Central Venous Line Associated Deep Vein Thrombosis in Hospitalized Children. Journal of Pediatric Hematology/Oncology 2019;41:e432-7. [DOI: 10.1097/mph.0000000000001512] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Kaddourah O, Numan L, Jeepalyam S, Abughanimeh O, Ghanimeh MA, Abuamr K. Venous thromboembolism prophylaxis in inflammatory bowel disease flare-ups. Ann Gastroenterol 2019;32:578-83. [PMID: 31700234 DOI: 10.20524/aog.2019.0412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
36 Zeng J, Gan HT. Letter: previous exposure to corticosteroids increases the risk of post-discharge venous thromboembolic events in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2019;50:712-3. [PMID: 31456298 DOI: 10.1111/apt.15411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 McCurdy JD. Letter: previous exposure to corticosteroids increases the risk of post-discharge venous thromboembolic events in patients with inflammatory bowel disease-author's reply. Aliment Pharmacol Ther 2019;50:714-5. [PMID: 31456301 DOI: 10.1111/apt.15457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Szakács Z, Csiszár B, Kenyeres P, Sarlós P, Erőss B, Hussain A, Nagy Á, Kőszegi B, Veczák I, Farkas N, Bódis E, Márta K, Szentesi A, Tőkés-Füzesi M, Berki T, Vincze Á, Tóth K, Hegyi P, Bajor J. Haemorheological and haemostatic alterations in coeliac disease and inflammatory bowel disease in comparison with non-coeliac, non-IBD subjects (HERMES): a case-control study protocol. BMJ Open 2019;9:e026315. [PMID: 30904871 DOI: 10.1136/bmjopen-2018-026315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Ding R, Xu J, He Z, Chen Y, Hultgårdh-Nilsson A, Liang C. Letter: different risks of venous thromboembolism in subsets of patients with inflammatory bowel diseases. Aliment Pharmacol Ther 2019;49:345-6. [PMID: 30663108 DOI: 10.1111/apt.15083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Dai C, Jiang M, Cao Q. Steroids and the Risk of Venous Thromboembolic Events in Inflammatory Bowel Disease. J Crohns Colitis 2018;12:627. [PMID: 29293967 DOI: 10.1093/ecco-jcc/jjx183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]